CubeSmart
CUBE NYSE Industrial REITs Financials FY2016βFY2025
CubeSmart's revenue rose 5.3% to $1.1 billion in fiscal 2025. Its net margin was 29.5%, down from 36.8% a year earlier. It paid out $508 million in dividends and buybacks. The diluted share count rose 0.9%.
What CubeSmart does
No business description yet.
- Legal name
- CUBESMART
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001298675-26-000010
0001298675
Revenue and margins
CubeSmart had $1.1B of revenue in fiscal 2025, up 5.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 14.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CubeSmart returned $508M to shareholders in fiscal 2025. The diluted share count rose 0.9%.
Value CubeSmart yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 229.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 28.1x Β· peers 28.2x Β· sector 27.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably CubeSmart can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $11.1M | $6.1M | $6.5M | $71.6M | $5.8M |
| Total assets | $6.5B | $6.3B | $6.2B | $6.4B | $6.6B |
| Total liabilities | $3.5B | $3.4B | $3.3B | $3.4B | $3.9B |
| Shareholders' equity | $2.9B | $2.8B | $2.8B | $2.9B | $2.7B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$7.3M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Christopher P MarrCEO, Director | Sold | 108,932 | $42.24 | $4.6M | Form 4 |
| Mar 3, 2026 | Jeffrey P FosterCLO & Secretary | Sold | 23,148 | $41.02 | $0.9M | Form 4 |
| Dec 15, 2025 | Christopher P MarrCEO, Director | Sold | 679 | $36.55 | $0.0M | Form 4 |
| Dec 12, 2025 | Christopher P MarrCEO, Director | Sold | 46,925 | $36.55 | $1.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.2% | β3.8% | β4.3% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| CubeSmart CUBE | $9.2B | 5.3% | β | β | β | 28.1x | β | |
| Rexford Industrial Realty REXR | $8.7B | 7.1% | β | 20.8% | β | β | β | Compare β |
| STAG Industrial STAG | $7.0B | 10.1% | β | 30.6% | β | 28.2x | β | Compare β |
| First Industrial Realty Trust FR | $7.2B | 8.6% | β | β | β | 19.8x | β | Compare β |
| EastGroup Properties EGP | $10.7B | 12.7% | β | 56.1% | β | 33.7x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | $559M | $598M | $644M | $679M | $823M | $1.0B | $1.1B | $1.1B | $1.1B |
| Gross profit | β | $377M | $401M | $434M | $456M | $571M | $716M | $756M | $749M | $772M |
| Operating income | $143M | $196M | β | β | β | β | β | β | β | β |
| Interest expense | $50.4M | $57.0M | $62.1M | $69.3M | $80.8M | $79.1M | $92.3M | $95.5M | $92.6M | $107M |
| Net income | $87.9M | $134M | $164M | $171M | $168M | $231M | $293M | $412M | $392M | $331M |
| Diluted EPS | $0.45 | $0.74 | $0.88 | $0.88 | $0.85 | $1.09 | $1.29 | $1.82 | $1.72 | $1.46 |
| Diluted shares | 0.18B | 0.18B | 0.19B | 0.19B | 0.19B | 0.21B | 0.23B | 0.23B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | $263M | $292M | $304M | $332M | $351M | $449M | $592M | $611M | $631M | $609M |
| Capital expenditure | β | $80.6M | $228M | $118M | β | β | β | β | β | β |
| Free cash flow | β | $211M | $76.8M | $213M | β | β | β | β | β | β |
| Depreciation and amortization | $162M | $146M | $143M | $164M | $157M | $232M | $315M | $205M | $210M | $263M |
| Stock-based compensation | $4.8M | $5.6M | $5.6M | $6.7M | $7.1M | $8.1M | $9.1M | $10.1M | $11.5M | $11.5M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $118M | $0.0M | $1.7B | $0.0M | $0.0M | $57.2M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $31.9M |
| Dividends paid | $149M | $195M | $221M | $244M | $256M | $274M | $387M | $442M | $462M | $476M |
| Dividends and buybacks | $149M | $195M | $221M | $244M | $256M | $274M | $387M | $442M | $462M | $508M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.0M | $5.3M | $3.8M | $54.9M | $3.6M | $11.1M | $6.1M | $6.5M | $71.6M | $5.8M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $65.6M | $65.8M | $65.8M | $65.7M | $65.7M | $65.6M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $3.5B | $3.5B | $3.8B | $4.0B | $4.8B | $6.5B | $6.3B | $6.2B | $6.4B | $6.6B |
| Total liabilities | $1.8B | $1.9B | $2.0B | $2.2B | $2.7B | $3.5B | $3.4B | $3.3B | $3.4B | $3.9B |
| Shareholders' equity | $1.7B | $1.6B | $1.7B | $1.8B | $1.8B | $2.9B | $2.8B | $2.8B | $2.9B | $2.7B |
| Margins | ||||||||||
| Gross margin | β | 67.5% | 67.1% | 67.4% | 67.1% | 69.4% | 71.0% | 71.9% | 70.2% | 68.7% |
| Operating margin | β | 35.0% | β | β | β | β | β | β | β | β |
| EBITDA margin | β | 61.1% | β | β | β | β | β | β | β | β |
| Net margin | β | 24.0% | 27.4% | 26.5% | 24.7% | 28.1% | 29.0% | 39.3% | 36.8% | 29.5% |
| FCF margin | β | 37.8% | 12.9% | 33.2% | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on equity | 5.3% | 8.2% | 9.8% | 9.7% | 9.2% | 9.8% | 10.3% | 14.7% | 13.8% | 11.9% |
| Return on assets | 2.7% | 3.8% | 4.5% | 4.4% | 3.8% | 4.1% | 4.5% | 6.6% | 6.2% | 5.1% |
| Growth | ||||||||||
| Revenue growth | β | β | 7.0% | 7.7% | 5.5% | 21.1% | 22.7% | 4.0% | 1.5% | 5.3% |
| Net income growth | 13.1% | 52.8% | 22.0% | 4.2% | β1.9% | 37.7% | 26.7% | 41.0% | β5.0% | β15.5% |
| EPS growth | 7.1% | 64.4% | 18.9% | 0.0% | β3.4% | 28.2% | 18.4% | 41.1% | β5.5% | β15.1% |
| FCF growth | β | β | β63.6% | 177.9% | β | β | β | β | β | β |
| Share count change | 5.5% | 1.1% | 2.2% | 3.3% | 1.8% | 5.2% | 10.2% | 0.2% | 0.4% | 0.9% |
| Financial health | ||||||||||
| Interest coverage | 2.8x | 3.4x | β | β | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | β | 14.4% | 38.1% | 18.4% | β | β | β | β | β | β |
| Stock comp / revenue | β | 1.0% | 0.9% | 1.0% | 1.1% | 1.0% | 0.9% | 1.0% | 1.1% | 1.0% |
| Payouts / FCF | β | 92.3% | 288.1% | 114.2% | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Accruals ratio | β5.3% | β4.5% | β3.9% | β4.1% | β4.2% | β3.9% | β4.6% | β3.2% | β3.8% | β4.3% |
Source: SEC EDGAR XBRL filings (CIK 0001298675). Data updated October 17, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.